2′-Hydroxychalcones as an alternative treatment for trichomoniasis in association with metronidazole.

Autor: das Neves, Raquel Nascimento, Sena-Lopes, Ângela, Alves, Mirna Samara Dié, da Rocha Fonseca, Bárbara, da Silva, Caroline Carapina, Casaril, Angela Maria, Savegnago, Lucielli, de Pereira, Claudio Martin Pereira, Ramos, Daniela Fernandes, Borsuk, Sibele
Předmět:
Zdroj: Parasitology Research; Feb2020, Vol. 119 Issue 2, p725-736, 12p
Abstrakt: The treatment for trichomoniasis, based on 5′-nitroimidazol agents, has been presenting failures related to allergic reactions, side effects, and the emergence of resistant isolates. There are no alternative drugs approved for the treatment of these cases; thus, the search for new active molecules is necessary. In this scenario, chalcones have been extensively studied for their promising biological activities. Here, we presented the synthesis of three hydroxychalcones (3a, b, and c), in vitro and in silico analyses against Trichomonas vaginalis. The in vitro biological evaluation showed that hydroxychalcone 3c presented anti-T. vaginalis activity, with complete death in 12 h of incubation at minimum inhibitory concentration (MIC) of 100 μM. 3c showed a dose-dependent cytotoxicity against mammalian VERO cell line, but the association of 3c at 12.5 μM and metronidazole (MTZ) at 40 μM showed 95.31% activity against T. vaginalis trophozoites after 24 h of exposure and did not affect the VERO cell growth, appearing to be a good alternative. In silico analysis by molecular docking showed that 3c could inhibit the activity of TvMGL (methionine gamma-lyase), TvLDH (lactate dehydrogenase), and TvPNP (purine nucleoside phosphorylase) affecting the T. vaginalis survival and also suggesting a different mechanism of action from MTZ. Therefore, these results propose that hydroxychalcones are promising anti-T. vaginalis agents and must be considered for further investigations regarding trichomoniasis treatment. [ABSTRACT FROM AUTHOR]
Databáze: Complementary Index
Externí odkaz: